Tricuspid regurgitation and right ventricular function after mitral valve surgery with or without concomitant tricuspid valve procedure  by Desai, Ravi R. et al.
A
C
D
Acquired Cardiovascular Disease Desai et alTricuspid regurgitation and right ventricular function after mitral
valve surgery with or without concomitant tricuspid valve procedureRavi R. Desai, BE,a LinaMaria Vargas Abello, MD,b Allan L. Klein, MD,c Thomas H.Marwick,MD, PhD,c
Richard A. Krasuski, MD,c Ying Ye, BS,a Edward R. Nowicki, MD,MS,b JeevananthamRajeswaran, MSc,d
Eugene H. Blackstone, MD,b,d and G€osta B. Pettersson, MD, PhDbFrom th
ments
Heart
Resea
This stu
Heart
ily En
Slosb
sen (t
Disclosu
Receive
public
Address
diova
Ave/M
0022-52
Copyrig
http://dx
1126Objectives: To study the effect of mitral valve repair with or without concomitant tricuspid valve repair on func-
tional tricuspid regurgitation and right ventricular function.
Methods: From 2001 to 2007, 1833 patients with degenerative mitral valve disease, a structurally normal
tricuspid valve, and no coronary artery disease underwent mitral valve repair, and 67 underwent concomitant
tricuspid valve repair. Right ventricular function (myocardial performance index and tricuspid annular
plane systolic excursion) was measured before and after surgery using transthoracic echocardiography for ran-
domly selected patients with tricuspid regurgitation grade 0, 1þ, and 2þ(100 patients for each grade) and 93 with
grade 3þ/4þ, 393 patients in total.
Results: In patients withmild (<3þ) preoperative tricuspid regurgitation, mitral valve repair alonewas associated
with reduced tricuspid regurgitation and mild worsening of right ventricular function. Tricuspid regurgitation of
2þor greater developed in fewer than 20%, and right ventricular function had improved, but not to preoperative
levels, at 3 years. In patients with severe (3þ/4þ) preoperative tricuspid regurgitation, mitral valve repair alone
reduced tricuspid regurgitation and improved right ventricular function; however, tricuspid regurgitation of 2þ
or greater returned and right ventricular function worsened toward preoperative levels within 3 years. Concom-
itant tricuspid valve repair effectively eliminated severe tricuspid regurgitation and improved right ventricular
function. Also, over time, tricuspid regurgitation did not return and right ventricular function continued to im-
prove to levels comparable to that of patients with lower grades of preoperative tricuspid regurgitation.
Conclusions: In patientswithmitral valve disease and severe tricuspid regurgitation,mitral valve repair alonewas
associated with improved tricuspid regurgitation and right ventricular function. However, the improvements were
incomplete and temporary. In contrast, concomitant tricuspid valve repair effectively and durably eliminated se-
vere tricuspid regurgitation and improved right ventricular function toward normal, supporting an aggressive ap-
proach to important functional tricuspid regurgitation. (J Thorac Cardiovasc Surg 2013;146:1126-32)Supplemental material is available online.
The effect of surgery to relieve left-sided valve disease, with
or without tricuspid valve repair (TVR), on right ventriculare Cleveland Clinic Lerner College of Medicine,a Cleveland, Ohio; Depart-
of Thoracic and Cardiovascular Surgeryb and Cardiovascular Medicine,c
and Vascular Institute, and Department of Quantitative Health Sciences,d
rch Institute, Cleveland Clinic, Cleveland, Ohio.
dy was supported in part by the Kenneth Gee and Paula Shaw, PhD, Chair in
Research (to Dr Blackstone), and the Peter and Elizabeth C. Tower and Fam-
dowed Chair in Cardiothoracic Research, James and Sharon Kennedy, the
urg Family Charitable Trust, Stephen and Saundra Spencer, and Martin Niel-
o Dr Pettersson).
res: Authors have nothing to disclose with regard to commercial support.
d for publication Dec 7, 2011; revisions received July 30, 2012; accepted for
ation Aug 23, 2012; available ahead of print Sept 24, 2012.
for reprints: G€osta B. Pettersson, MD, PhD, Department of Thoracic and Car-
scular Surgery, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid
ail Stop J4-1, Cleveland, OH 44195 (E-mail: petterg@ccf.org).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.08.061
The Journal of Thoracic and Cardiovascular Sur(RV) function in patients with functional tricuspid regurgi-
tation (TR) is of great interest, but few studies have been
published. In our companion study, we found that RV func-
tion was markedly abnormal in patients with severe (grade
3þ/4þ) TR.1 This was true for the myocardial performance
index (MPI), which reflects global RV systolic and diastolic
function, and tricuspid annular plane systolic excursion
(TAPSE), which reflects longitudinal systolic function.2
Whether the TR was caused by RV dysfunction or vice
versa remained unclear. The decreased function suggested
by MPI and TAPSE, both being load-sensitive indexes,
could reflect true RV dysfunction or altered pre- and
afterload.2
All these patients underwent mitral valve repair (MVR) to
correct theirmitral regurgitation (MR).Most patientswith se-
vere TR also underwent concomitant TVR; patients with less
severe TR underwent only MVR. It is well known that MVR
reduces pulmonary pressure and RVafterload; however, cor-
recting TR increases RVafterload. CorrectingMR could also
influence the right heart by changing the atrial and ventricular
septal positions from the shifting volume and pressure loads.gery c November 2013
Abbreviations and Acronyms
MPI ¼ myocardial performance index
MR ¼ mitral regurgitation
MVR ¼ mitral valve repair
RV ¼ right ventricular
TAPSE ¼ tricuspid annular plane systolic excursion
TR ¼ tricuspid regurgitation
TTE ¼ transthoracic echocardiogram
TV ¼ tricuspid valve
TVR ¼ tricuspid valve repair
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study cohort with no evidence of either organic tricuspid
valve (TV) alteration or coronary artery disease, we attemp-
ted to answer the following questions about TR and RV
function after correcting the left-sided valve disease with
or without concomitant TVR:
 What are the early, intermediate-, and long-term effects
of MVR alone versus MVR with concomitant TVR on
TR and RV function?
 Do the early postoperative measures of RV function on
predischarge transthoracic echocardiograms (TTEs) cor-
relatewith the preoperativemeasures of these same quan-
tities, and what factors, including preoperative TR and
the operation, are associated with their changes after
MVR alone versus MVR with concomitant TVR?
 Does the apparently diminished preoperative RV dys-
function associated with severe preoperative TR improve
during follow-up after surgery?
 What factors, including preoperative TR, RV function,
and the operation (MVR alone vsMVRwith concomitant
TVR), are associated with the temporal pattern of RV
function observed during follow-up?PATIENTS AND METHODS
The patient details and study design have been reported in the compan-
ion study.1 In brief, for 2726 patients undergoing mitral valve surgery at
Cleveland Clinic, a random sample of 100 patients was selected for each
preoperative TR grade 0þ, 1þ, and 2þon TTE. All 93 patients with grade
3þor 4þTRwere included, for a total of 393 patients. Patient characteristics
and preoperative echocardiographic findings are presented in Tables E1 and
E2. Characteristics of the patients included in the present studywere similar
to those of patients not included, as analyzed by TR grade (Tables E3-E5).
Data Sources
All the data used for the present study were approved for use in research
by the institutional review board, with patient consent waived. In addition
to clinical and preoperative echocardiographic data described in the com-
panion report,1 TR, TAPSE, and MPI were measured de novo, as previ-
ously described, on all postoperative TTEs available at Cleveland Clinic
for these patients.2 Predischarge and follow-up TR was assessed on 707
TTEs for 388 patients (99% of total), and MPI and TAPSE on 643 TTEs
for 355 patients (90% of total). The distribution of TTEs over time accord-
ing to TR grade is shown in Table E6.The Journal of Thoracic and CarNo fixed schedule for the postoperative surveillance TTEs was imposed.
A total of 38% of patients had more than 1 TTE recorded, and 20% had
more than 2. The number of TTEs per patient ranged from 1 to 10
(mean, 2). However, in 390 patients followed up at Cleveland Clinic, the
pattern of intervals for the TTEs suggested a degree of regularity
(Figure E1), and results (data not shown) in this group were entirely con-
sistent with those presented for the group as a whole.
The intra- and interobserver variability of TAPSE andMPIwas studied in
17 randomly selected patients. The intraobserver (R.D.) correlation was
r ¼ 0.97 for TAPSE (Figure E2, A) and r ¼ 0.91 for MPI (Figure E2, B).
The interobserver variability between investigator (R.D.) and sonographer
was r¼ 0.61 for TAPSE (Figure E2, C) and r¼ .88 for MPI (Figure E2,D).Statistical Analysis
Early response to surgery. Of the 393 patients, 3 (3.0%) of the
100 with grade 2þMR preoperatively underwent TVR (2 ring repair, 1 su-
ture repair) concomitant with left-sided valve surgery, and 64 (69%) of the
93 with grade 3þ/4þTR preoperatively underwent TVR (60 ring repair, 3
suture repair) or replacement (n ¼ 1). Postoperatively, predischarge
TTEs were retrievable and measurable for 96 of 100 patients with preoper-
ative TR grade 0, 88 of 100 with TR grade 1þ, 93 of 100 with grade TR 2þ,
and 85 of 93 (91%) with TR grade 3þ/4þ. TR grade could be measured on
362 predischarge TTEs, TAPSE on 349, and MPI on 348.
Analyses focused on the comparison of TR grade, TAPSE, and MPI
from preoperative to predischarge levels. This included paired t-testing,
correlation analyses, and multivariable ordinal logistic regression (TR
grade) and linear regression analyses using the preoperative variables
(TAPSE, MPI; Appendix E1). These analyses were performed overall,
stratified according to whether a TV procedure had been performed and ac-
cording to preoperative TR grade. For these multivariable analyses, we
used ‘‘bagging’’ for variable selection.3 Automated stepwise regression
was performed on 1000 bootstrap data sets with P¼ .05 used for the reten-
tion of variables. Thereafter, those present in 50% or more of the analyses
were retained in the final model.
Course of postoperative TR and RV function. To assess the
temporal trend of TR, TAPSE, and MPI after surgery, all postoperative and
follow-up TTEs were analyzed longitudinally for pattern of change across
time. A nonlinear mixed model4,5 was used to resolve the number of time
phases to form a temporal decomposition model and to estimate the
shaping parameters at each phase. Although each phase is defined across
all time, each dominates the others in a different period from surgery
(Figures E3-E5). We therefore used descriptive terms such as ‘‘early’’ and
‘‘late’’ to indicate the period of this dominance. Mixed-model regression6
for ordinal and continuous repeatedmeasurements (SASPROCNLMIXED,
SAS Institute, Inc, Cary, NC)was used to implement the temporal decompo-
sition model. The temporal pattern of prevalence of individual categories of
the ordinal longitudinal data was obtained by averaging the patient-specific
probability estimates. Because the underlying temporal patterns might be
different for patients who underwent a TV procedure than in those who
did not, we performed separate temporal pattern analyses for the 2 groups.
Missing values. We used a fivefold imputation7 with the Markov
Chain Monte Carlo technique to impute the missing values for variables
considered in multivariable analyses (PROCMI, SAS, version 9.1, SAS In-
stitute, Inc), but not for outcomes. The missing information is indicated in
each table. For variable selection, only the first imputed data set was used.
Having established a model, we estimated the regression coefficients and
their variance–covariance matrix for all 5 data sets. These were combined
using PROC MIANALYZE (SAS Institute, Inc).
Presentation. Continuous variables are summarized as the mean 
standard deviation and as equivalent 15th, 50th (median), and 85th percen-
tiles when their distribution was skewed. Comparisonsweremade using the
Wilcoxon rank-sum test. Categorical data are summarized by frequencies
and percentages, with comparisons made using the c2 test. All analysesdiovascular Surgery c Volume 146, Number 5 1127
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Inc). Uncertainty is expressed by 68% confidence limits equivalent to 1
standard error.RESULTS
Effects of MVR Alone on TR and RV Function
MVR alone (which reduced MR to grade 0 or 1þin 98%
of patients) reduced TR, irrespective of the preoperative
grade of TR, although patients with grade 2þ or more TR
were more likely to have the same higher grade of TR post-
operatively. Over time, patients with lower grades of preop-
erative TR (0-2þ) showed very little increase in TR, but
those with severe TR preoperatively showed a return of
grade 2þor more TR within 3 years (Figure 1).
Parallel to the improvement in TR, amild reduction of RV
function was observed in patients with lower grade 0 to 2þ
TR and normal RV function. For grade 0 and 1þ TR, RV
function was still normal, but for grade 2þTR, it was lower
than normal (Figures 2 and 3). However, patients with
severe TR and RV dysfunction preoperatively actually
showed both reduced TR and improved RV function after
MVR alone. RV function improvement was observed for
both TAPSE and MPI. These improvements were,
however, temporary, and, at 3 years, both TR and RV
dysfunction had returned to the preoperative levels.Effects of MVR and Concomitant TVR on TR and
RV Function
Of the patients with grade 2þTR and those with severe
TR, 3 and 64 underwent a concomitant TV procedure
(66 repair and 1 replacement) and 97 and 29 did not,
respectively.FIGURE 1. Percentage of patients with grade 2þ/3þ/4þtricuspid regurgitation (
grades. Open diamonds and blue line indicate patients with preoperative TR gr
squares and purple line, thosewith preoperative grade 2þ; closed circles and blac
(TV) procedure; and open triangles and red line, those with preoperative grade 3
to preoperative TR grade and TV procedure; and (B) TR grade 2þ/3þ/4þpostope
procedure was performed.
1128 The Journal of Thoracic and Cardiovascular SurThe TV procedure effectively reduced severe TR to 0 to
1þ, and this improvement was stable over time, in contrast to
when severe TR was not addressed (Table E7 and Figure 1).
MVR with or without TVR reduced RV systolic pressure
(Figure E6).
In patients with severe TR and impaired RV function pre-
operatively, RV function (both TAPSE and MPI) improved
immediately after surgery, irrespective of whether the pa-
tients had undergone concomitant TVR (Figures 2 and 3).
This immediate improvement was more pronounced if
TVR had not been performed. After a brief decrease in
TAPSE, both TAPSE and MPI improved for the first 6
months, irrespective of whether the patients had
undergone a TV procedure. After TVR, this improvement
continued for both measures, but without TVR, RV
function started to progressively decline at 6 months in
parallel with a return of TR to preoperative levels
(Figures 2 and 3). At 3 years, both TAPSE and MPI were
normal after TVR. However, without TVR, both TR and
RV dysfunction had returned to preoperative levels.
Predictors of RV Function in Response to Surgery
Immediate response. In general, the distribution of both
TAPSE andMPI was toward worse RV function than preop-
eratively, except for patients with grade 3þ/4þTR and poor
RV function preoperatively. These trends were apparent in
scattergrams of change for individual patients (Figure 4
and Figure E7). On the predischarge TTEs, TAPSE and
MPI, although improved, were worse in patients with pre-
operative TR grade 2þor worse.
Temporal patterns. Preoperative factors associated with
higher postoperative TR grade. Overall, a higherTR) grades postoperatively over time stratified by preoperative (pre-op) TR
ade 0; open circles and green line, those with preoperative grade 1þ; open
k line, thosewith preoperative grade 3þ/4þand undergoing a tricuspid valve
þ/4þand no TV procedure. A, TR grade 2þ/3þ/4þpostoperatively according
ratively for patients with severe preoperative TR according to whether a TV
gery c November 2013
FIGURE 2. Tricuspid annular plane systolic excursion (TAPSE) over time stratified by preoperative tricuspid regurgitation (TR) grade. Depiction by pre-
operative TR grade and tricuspid valve (TV) procedure as in Figure 1. A, TAPSE for all preoperative TR grades and TV procedure. B, TAPSE for patients
with severe preoperative TR according to whether a TV procedure was performed.
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associated with higher predischarge TR. In the early phase,
which is the immediate effect of surgery, higher preoperative
MPI and absence of a TV procedure were associated with
a higher postoperative TR grade. In the late phase, lower
ejection fraction, higher grade of MR, and absence of
a TV procedure were associated with a higher postoperative
TR grade (Table 1). No statistically significant association
was found between preoperative TAPSE and postoperative
TR in any phase (P>.2), nor was any interaction seen be-
tween preoperativeMPI and preoperativeTAPSEon postop-
erative TR during either phase (P ¼ .3).
Preoperative factors associated with lower (worse) TAPSE.
Overall, a higher grade of preoperative TR, higher heart rate,
larger left atrial systolic area, lower left ventricular ejectionFIGURE 3. Mean myocardial performance index (MPI) over time stratified b
procedure. Depiction by preoperative TR grade and TV procedure as in Figure
patients with severe preoperative TR according to whether a TV procedure wa
The Journal of Thoracic and Carfraction, and higher blood urea nitrogenwere associatedwith
lower postoperative TAPSE (Table 2). In the early phase,
only a TV procedure was associated with lower postopera-
tive TAPSE. In the late phase, absence of a TV procedure,
higher bilirubin level, and lower TV fractional area shorten-
ing were associated with lower postoperative TAPSE.
Preoperative factors associated with higher (worse) MPI.
Overall, a higher grade of preoperative TR, higher heart
rate, larger left atrial volume index, lower MR grade, a his-
tory of chronic obstructive pulmonary disease, and older age
were associated with higher postoperative MPI (Table 3). In
the early phase, a history of hypertension, higher mean
systemic arterial pressure, and higher preoperative MPI
were associated with higher postoperative MPI. No factors
were associated with postoperative MPI in the late phase.y preoperative tricuspid regurgitation (TR) grades and tricuspid valve (TV)
1. A, MPI for all preoperative TR grades and TV procedure. B, MPI for
s performed.
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FIGURE 4. Scattergram of preoperative (pre-op) versus postoperative (predischarge) myocardial performance index (MPI) according to preoperative
grade of tricuspid regurgitation (TR). Each symbol represents 1 patient. Open circles indicate no tricuspid procedure was performed; filled circles indicate
tricuspid procedure was performed. Dashed lines represent upper limit of normal. Corresponding data for tricuspid annular plane systolic excursion pre-
sented in Figure E7. A, n ¼ 83; (B) n ¼ 89; (C) n ¼ 91; and (D) n ¼ 86.
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Functional TR secondary to left-sided heart disease has
been thought to be caused by changes in RV geometry,
the size and shape of the TV annulus, and the relative dis-
placement of papillary muscles.8-10 In accordance withTABLE 1. Risk factors associated with higher grade of postoperative
tricuspid regurgitation
Factor Estimate ± SE
P
value
Reliability
(%)*
Overall
Older agey 1.1  0.23 <.0001 77
Women 1.02  0.26 .0001 52
Higher grade of preoperative TRz 1.7  0.53 .001 71
Early phase
Higher preoperative MPIx 4.1  1.8 .02 61
Absence of TV procedure 4.2  1.1 .0001
Late phase
Lower LV ejection fractionjj 3.9  1.3 .003 61
Higher MR grade 1.4  0.56 .02 78
Absence of TV procedure 2.3  0.58 <.0001
LV, Left ventricular; MPI, myocardial performance index; MR, mitral regurgitation;
SE, standard error; TR, tricuspid regurgitation; TV, tricuspid valve. *Percentage of
times variable appeared in 500 bootstrap models. y(Age/50)2, squared transformation.
z(1/[TR gradeþ1]), inverse transformation. xMPI2, squared transformation. jj(50/ejec-
tion fraction), inverse transformation.
1130 The Journal of Thoracic and Cardiovascular Surthis theory, eliminating MR should initiate reverse RV
remodeling and reduce TR. Our findings confirmed that
MVR alone reduced RV systolic pressure and improved
TR of every severity grade.
In our companion report, however, RV dysfunction
stood out as having a more consistent association with se-
vere functional TR than any other measure of RV remod-
eling. Other than the efficiency and durability of TVR in
reducing TR, little information is available on the effect
of these procedures on RV reverse remodeling and RV
dysfunction. In patients with grade 0 to 2þ TR, MVR in-
duced a mild early reduction of RV function; however,
the function remained at low normal, and a few experi-
enced worsening of TR, as observed by Yilmaz and col-
leagues.11 We do not have a good explanation for this
mild RV dysfunction, but speculate that it could be non-
specific effects related to suboptimal myocardial protec-
tion of the right ventricle during surgery, perioperative
management of volume (preload) and drugs, or just a gen-
eral effect of surgery. RV function quickly recovered, but
not to preoperative levels. Although this suggests a possi-
ble disconnect between TR and RV function, these pa-
tients did not have much TR preoperatively. In fact, in
patients with severe TR, MVR alone improved RVgery c November 2013
TABLE 2. Preoperative risk factors associated with lower (worse)
postoperative TAPSE
Factor Estimate ± SE
P
value
Reliability
(%)*
Overall
Higher preoperative TR 100
1þvs 0 0.13  0.047 .006
2þvs 0 0.45  0.047 <.0001
3þ/4þvs 0 0.50  0.051 <.0001
Higher heart ratey 0.16  0.079 .05 60
Larger LA area in systolez 4.9  1.8 .005 99
Lower LV ejection fractionx 0.22  0.087 .01 65
Higher BUNjj 0.052  0.019 .005 77
Early phase
Shorter RV base to apex length{ 0.76  0.41 .06 85
TV procedure 1.04  0.52 .03
Late phase
Lower TV fractional shortening# 7.04  4.02 .07 88
Higher bilirubin** 0.72  0.24 .006 83
No TV procedure 0.72  0.26 .006
BUN, Blood urea nitrogen; LA, left atrial; LV, left ventricular; RV, right ventricular;
SE, standard error; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid
regurgitation; TV, tricuspid valve. *Percentage of times factor appeared in 500 boot-
strap models. y(75/heart rate), inverse transformation. z(1/LA area in systole), inverse
transformation. x(50/LV ejection fraction), inverse transformation. jj(BUN/20)2,
squared transformation. {(RV base to apex length/7)2, squared transformation.
#(TV fractional shortening)2, squared transformation. **Ln(bilirubin), natural loga-
rithmic transformation.
TABLE 3. Preoperative risk factors associated with greater (worse)
postoperative MPI
Factor Estimate ± SE
P
value
Reliability
(%)*
Overall
Greater preoperative TR 100
1þvs 0 0.098  0.022 <.0001
2þvs 0 0.16  0.024 <.0001
3þ/4þvs 0 0.12  0.036 .0009
History of COPD 0.12  0.027 <.0001 95
Higher heart ratey 0.034  0.019 .07 50
Older agez 0.038  0.015 .01 88
Larger LA volume indexx 0.039  0.018 .03 85
Lower MR 0.059  0.028 .03 42
TV procedure 0.036  0.032 .3
Early phase
History of hypertension 0.033  0.016 .04 42
Greater mean systemic
arterial pressurejj
6.7  4.02 .09 58
Greater preoperative MPI{ 0.055  0.028 .05 58
Late phase
None
COPD, Chronic obstructive pulmonary disease; LA, left atrial;MPI, myocardial per-
formance index; MR, mitral regurgitation; SE, standard error; TR, tricuspid regurgi-
tation; TV, tricuspid valve. *Percentage of times factor appeared in 500 bootstrap
models. y(75/heart rate), inverse transformation. z(Age/50)2, squared transformation.
xLn(LA volume index), natural logarithmic transformation. jj(1/mean arterial pres-
sure), inverse transformation. {MPI2, squared transformation.
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these improvements did not last.
The effectiveness of TVRwas impressive, because it both
eliminated severe TR and improved RV function. Immedi-
ate improvement of RV function, by both TAPSE and
MPI, was less after concomitant TVR than after MVR
alone. However, the effect of TVR was durable over time,
with a minimal return of TR, such as was observed by
Chan and colleagues,12 and continued improvement of RV
function, which eventually reached low normal levels for
both TAPSE and MPI.13 It is certainly good news that in
this setting of severe functional TR secondary to mitral
valve disease, RV dysfunction was reversible, returning to
close to normal after TVR and remaining stable. This oc-
curred even though the patients who had undergone con-
comitant TVR were sicker than those with severe TR
undergoing MVR alone, although the RV dysfunction was
the same (Table E8). In contrast, the early improvements
of TR and RV function after MVR alone were eliminated
within 3 years.
The interaction between TR and RV function appears to
be in both directions; not only does RV dysfunction affect
the severity of TR, but reduced TR is also associated with
improved RV function. Functional TR is secondary to RV
dysfunction and vice versa.
An additional important question relates to how well
TAPSE and MPI reflect RV function and changes in RVThe Journal of Thoracic and Carfunction after surgery. TAPSE measures longitudinal sys-
tolic function and has been shown to correlate highly with
MRI-derived volumes14 and radionuclide ejection frac-
tion.15 The MPI primarily measures contractility, and its
calculation involves consideration of energy-dependent pe-
riods of contraction, ejection, and diastolic relaxation.16
The use of TAPSE and MPI as measures of postoperative
RV function has not been validated.2 The temporal pattern
of TAPSE and MPI was very similar, with a significant pos-
itive relationship between the pre- and postoperative values.
Our findings are similar to a recent MRI study in which RV
volumes and ejection fraction were measured in patients un-
dergoing surgical repair of severe TR.13 This indicates that
TAPSE and MPI are equally useful measures of RV func-
tion postoperatively as preoperatively in our group of pa-
tients, and this seemed to also be true after concomitant
TVR. The factors associated with worse RV function post-
operatively (Tables 2 and 3) make sense because these
factors are all indicators of more advanced disease and
right heart failure, with expected effects on the right heart.
Study Limitations
The study population was patients with degenerative
mitral valve disease and secondary ‘‘functional’’ TR. There-
fore, the results might not be applicable to other patient cat-
egories with TR and RV dysfunction. Although our findings
make sense and fit into an understandable pattern, validationdiovascular Surgery c Volume 146, Number 5 1131
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against other qualitative and quantitative measures of RV
function needs additional study. In particular, validation of
RV function measures after cardiac surgery is important, be-
cause the surgery and perioperative management include so
manymanipulations that could affect thesemeasures.Never-
theless, wewere impressed by the consistency of our results,
causing us to believe TAPSE and MPI are relatively good
measures of intrinsic RV function.
All echocardiographic measures are subject to intra- and
interobserver variability. To this is added the variability
across time because equipment has changed. For the present
study, intraobserver variability was excellent, with little ev-
idence of bias. Thus, for all measurements reported, which
were made by 1 investigator, we believe the results are re-
producible. The agreement between investigator and sonog-
rapher was more variable, particularly for TAPSE. This
surprised us because of the ease with which TAPSE can
be measured.
This was a single-institution, observational study; thus,
echocardiographic follow-up was, to an unknown extent,
opportunistic rather than systematic. However, a large num-
ber of postoperative echocardiograms were available to en-
able powerful longitudinal data analysis of multiple
measurements over time instead of independent time
points.17
Study Implications
In patients with degenerative mitral valve disease and
functional TR, MVR alone was associated with mild im-
pairment of RV function in patients with lower grades of
TR. In patients with severe TR, both TR and RV function
improved. However, these improvements were incomplete
and temporary, with both TR and RV dysfunction returning
to preoperative levels within 3 years. In contrast, concomi-
tant TVR durably eliminated severe TR and was associated
with improved RV function toward normal, supporting an
aggressive approach to important functional TR.
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APPENDIX E1. Variables used in analyses
Patient
Demographic Age (y), gender, weight (kg), height (cm), body surface area (m2), body mass index (kg/m2)
Symptoms NYHA functional class (I-IV)
Valve pathologic features Mitral valve regurgitation, aortic regurgitation
Coronary anatomy Left main trunk disease (% stenosis), left anterior descending coronary artery system disease (maximum%
stenosis), right coronary artery system disease (maximum% stenosis), left circumflex coronary artery system
disease (maximum% stenosis)
Cardiac comorbidity Atrial fibrillation, hypertension, history of cardiac disease, complete heart block/pacer, ventricular arrhythmia
Heart hemodynamics Mean arterial pressure, central venous pressure, heart rate
Noncardiac comorbidity Treated diabetes, insulin-treated diabetes, history of peripheral arterial disease, history of smoking, carotid
disease, popliteal disease, creatinine (mg/dL), BUN (mg/dL), bilirubin (mg/dL), creatinine clearance,
hematocrit (%), GFR, history of renal disease, previous stroke, model for end-stage liver disease score
Experience Date of operation (years since 1/1/2001)
Left ventricle
Structure Inner diameter in diastole (cm), inner diameter in systole (cm), diastolic volume (mL), systolic volume (mL),
diastolic volume index (mL/m2), systolic volume index (mL/m2), dilated left ventricle
Function Fractional shortening, ejection fraction (%), relative wall thickness (wall stress), left ventricular dysfunction
(grades: none, mild, mild to moderate, moderate, moderate to severe, severe)
Mass Mass (g), mass index (g/m2), posterior wall thickness (cm), septal thickness (cm)
Left atrium LA diameter, LA volume, volume index, LA systolic area
Right heart
Ventricle
Remodeling Qualitative right ventricular dilation (none, mild, moderate, severe) and base to apex length (cm), tricuspid valve
tethering distance (cm) and tethering area (cm2)
Function Qualitative right ventricular dysfunction (none, mild, moderate, severe), systolic pressure (mm Hg), TAPSE (cm),
MPI, tricuspid valve diameter shortening (cm), fractional shortening
Atrium
Morphology Qualitative right atrial dilation (none, mild, moderate severe) at end-systole (cm2)
BUN, Blood urea nitrogen; GFR, glomerular filtration rate; LA, left atrial; NYHA, New York Heart Association; TAPSE, tricuspid annular plane systolic excursion; MPI, myo-
cardial performance index.
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FIGURE E1. Number of patients with postoperative echocardiograms at
monthly postoperative intervals. Note the 6-month increases in echocardio-
graphic measurements, suggestive of regularly scheduled follow-up.
FIGUREE2. Intra- and interobserver variability of right ventricular function measures: tricuspid annular plane systolic excursion (TAPSE) andmyocardial
performance index (MPI). Dashed line is line of identity. A, Intraobserver variability for TAPSE: r ¼ 0.97 (linear regression, measurement 2 ¼ 0.20þ
0.913measurement 1). B, Intraobserver variability for MPI: r¼ 0.91 (linear regression, measurement 2¼ 0.14þ0.813measurement 1). C, Interobserver
variability, investigator versus sonographer: r¼ 0.61 (linear regression, sonographer¼ 0.61þ0.623 investigator). D, Interobserver variability, investigator
versus sonographer: r ¼ 0.88 (linear regression, sonographer ¼ 0.10þ0.92 3 investigator).
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FIGURE E3. Temporal decomposition of temporal trend of postoperative
tricuspid regurgitation (TR). Blue curve indicates early phase, and red
curve, late phase. A, Without tricuspid valve procedure. B, With tricuspid
valve procedure.
FIGUREE4. Temporal decomposition of temporal trend of postoperative
tricuspid annular plane systolic excursion (TAPSE). Red curve represents
constant risk; yellow curve, early phase; and blue curve, late phase.
A, Without tricuspid valve procedure. B, With tricuspid valve procedure.
Desai et al Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery c Volume 146, Number 5 1132.e3
A
C
D
FIGURE E5. Temporal decomposition of temporal trend of postoperative
myocardial performance index (MPI). Blue curve represents early phase,
and yellow curve, late phase. A, Without tricuspid valve procedure.
B, With tricuspid valve procedure.
FIGUREE6. Scatter plot depicting relationship between preoperative and
postoperative (predischarge) right ventricular systolic pressure (RVSP)
stratified by preoperative tricuspid valve regurgitation grades. Open dia-
monds, patients with preoperative tricuspid regurgitation grade 0; open cir-
cles, those with preoperative grade 1þ; open squares, those with
preoperative grade 2þ; closed circles, patients with preoperative grade 3þ
or 4þand undergoing TV procedure; and open triangles, those with preop-
erative grade 3þor 4þand no TV procedure.
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TABLE E1. Preoperative patient characteristics according to tricuspid regurgitation grade
Variable
TR grade
P valuey
0 (n ¼ 100) 1þ (n ¼ 100) 2þ (n ¼ 100) 3þ/4þ (n ¼ 93)
Patients (n)* Value Patients (n)* Value Patients (n)* Value Patients (n)* Value
Demographics
Age (y) 100 53  10 100 57  12 100 65  12 93 68  11 <.0001
Women 100 31 (31) 100 37 (37) 100 34 (34) 93 52 (56) .002
Body surface area (m2) 100 2.0  0.23 100 2.0  0.25 100 2.0  0.23 93 1.9  0.24 .001
Cardiac morbidity
NYHA functional class 100 100 100 93 .04
I 33 (33) 28 (28) 36 (36) 18 (19)
II 53 (53) 63 (63) 52 (52) 54 (58)
III 14 (14) 8 (8.0) 11 (11) 20 (22)
IV 0 (0) 1 (1.0) 1 (1.0) 1 (1.1)
Noncardiac comorbidity
Cholesterol (mg/dL) 93 200  38 87 200  43 92 190  29 85 180  35 <.0001
Bilirubin (mg/dL) 100 0.72  0.59 97 0.74  0.39 99 0.8  0.41 89 0.87  0.52 .03
BUN (mg/dL) 99 17  4.8 100 18  5.3 100 19  6.0 93 22  8.8 <.0001
Creatinine (mg/dL) 100 0.93  0.19 99 0.96  0.23 99 1.0  0.24 92 1.1  0.7 .02
Hematocrit (%) 98 42  3.5 99 41  5.4 99 41  4.0 90 40  4.7 .0001
MELD score 100 7.2  1.4 100 7.4  1.6 100 8.0  2.4 93 8.6  2.4 <.0001
Data presented as mean  standard deviation or n (%). BUN, Blood urea nitrogen;MELD, model for end-stage liver disease; NYHA, New York Heart Association; TR, tricuspid
regurgitation. *Patients with data available. yFor categorical variables, Mantel-Haenzel test of linear trend with increasing tricuspid valve regurgitation grade; for continuous
variables, equivalent test of Pearson correlation coefficient.
FIGUREE7. Scattergram of preoperative (pre-op) versus postoperative (predischarge) tricuspid valve annular plane systolic excursion (TAPSE) according
to preoperative grade of tricuspid regurgitation (TR). Each symbol represents 1 patient. Open circles indicate no tricuspid procedure was performed; filled
circles indicate a tricuspid procedure was performed. Dashed lines represent lower limit of normal.
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TABLE E2. Left and right heart echocardiographic findings according to tricuspid regurgitation grade
Variable
TR grade
P valuey
0 (n ¼ 100) 1þ (n ¼ 100) 2þ (n ¼ 100) 3þ/4þ (n ¼ 93)
Patients (n)* Value Patients (n)* Value Patients (n)* Value Patients (n)* Value
MV regurgitation 100 100 100 93 .4
Moderate 0 (0) 1 (1.0)z 0 (0) 0 (0)
Moderately severe 7 (7.0) 8 (8.0) 4 (4.0) 10 (11)
Severe 93 (93) 91 (91) 96 (96) 83 (89)
LV mass index (g/m2) 94 140  110 95 130  30 95 140  36 87 130  36 .5
LA diameter (cm) 87 4.6  0.67 92 4.7  0.81 93 5.0  0.85 84 5.1  0.94 <.0001
LV end-diastolic volume (mL) 95 160  44 97 150  46 95 150  45 87 140  40 .01
LV end-systolic volume (mL) 95 49  24 97 50  26 95 46  20 87 46  24 .2
LV mass (g) 94 280  220 95 250  73 95 270  80 87 240  69 .1
LV ejection fraction (%) 100 58  7.0 99 59  7.8 100 58  5.7 93 56  8.1 .05
RVSP (mm Hg) 61 31  8.8 85 36  12 94 45  14 88 51  20 <.0001
Tricuspid valve
Regurgitation velocity (cm/s) 62 250  46 86 280  49 94 310  51 89 330  71 <.0001
Tethering distance (cm) 99 0.44  0.18 99 0.63  0.23 98 0.55  0.23 91 0.71  0.30 <.0001
Tethering area (cm2) 99 0.40  0.32 99 0.59  0.35 98 0.48  0.33 91 0.74  0.56 <.0001
Annular shortening (cm) 99 0.36  0.27 99 0.37  0.28 98 0.34  0.26 91 0.40  0.36 .6
Annular shortening fraction 99 0.11  0.08 99 0.11  0.08 98 0.10  0.08 91 0.11  0.10 .6
RV dilation 98 95 92 89 .006
None 97 (99) 94 (99) 85 (92) 78 (88)
Mild 1 (1.0) 1 (1.1) 5 (5.4) 4 (4.5)
Moderate 0 (0) 0 (0) 2 (2.2) 6 (6.7)
Severe 0 (0) 0 (0) 0 (0) 1 (1.1)
RV base to apex length (cm) 99 6.8  0.91 99 7.4  0.98 98 7.4  0.87 91 7.4  0.96 <.0001
RA dilation 98 95 92 84 <.0001
None 74 (76) 60 (63) 55 (60) 29 (35)
Mild 24 (24) 28 (29) 29 (32) 29 (35)
Moderate 0 (0) 7 (7.4) 8 (8.7) 23 (27)
Severe 0 (0) 0 (0) 0 (0) 3 (3.6)
RA systolic area (cm2) 99 18  4.4 99 19  4.8 98 22  5.9 91 28  8.4 <.0001
Pulmonary regurgitation 100 100 100 93 <.0001
None 100 (100) 24 (24) 7 (7.0) 5 (5.4)
Mild 0 (0) 75 (75) 7 (7.0) 4 (4.3)
Moderate 0 (0) 1 (1.0) 86 (86) 5 (5.4)
Moderately severe 0 (0) 0 (0) 0 (0) 64 (69)
Severe 0 (0) 0 (0) 0 (0) 15 (16)
Qualitative RV dysfunction 98 95 96 90 <.0001
None 97 (99) 93 (98) 85 (89) 72 (80)
Mild 0 (0) 2 (2.1) 7 (7.3) 9 (10)
Moderate 1 (1) 0 (0) 2 (2.1) 7 (7.8)
Severe 0 (0) 0 (0) 2 (2.1) 2 (2.2)
TAPSE 100 2.3  0.45 100 2.2  0.38 100 2.0  0.39 93 1.1  0.25 <.0001
MPI 100 0.28  0.09 100 0.32  0.06 100 0.38  0.15 93 0.82  0.28 <.0001
Data presented as mean  standard deviation or n (%). LV, Left ventricular;MPI, myocardial performance index;MV, mitral valve; RA, right atrial; RV, right ventricular; RVSP,
right ventricular systolic pressure; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation. *Patients with data available. yFor categorical variables, Mantel-
Haenzel test of linear trend with increasing tricuspid valve regurgitation grade; for continuous variables, equivalent test of Pearson correlation coefficient. zLong-standing atrial
fibrillation, failed medical therapy.
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TABLE E3. Patient characteristics for tricuspid regurgitation grade 0 group
Variable
Patients not included Patients included
P valuePatients (n)* Value Patients (n)* Value
Demographics
Age (y) 692 53  12 100 53  10 .9
Women 692 186 (27) 100 31 (31) .4
Body surface area (m2) 692 2.0  0.24 100 2.0  0.23 .2
Cardiac morbidity
NYHA functional class 692 100 .6
I 264 (38) 33 (33)
II 345 (50) 53 (53)
III 78 (11) 14 (14)
IV 5 (0.72) 0 (0)
Noncardiac comorbidity
Cholesterol (mg/dL) 622 200  34 93 200  38 .9
Bilirubin (mg/dL) 675 0.73  0.4 100 0.72  0.59 .2
BUN (mg/dL) 683 18  5.8 99 17  4.8 .03
Creatinine (mg/dL) 686 0.95  0.22 100 0.93  0.19 .2
Hematocrit (%) 685 42  4.4 98 42  3.5 .7
Echocardiography
Mitral regurgitation grade 692 100 .5
1þ 1 (0.14)y 0 (0)
2þ 6 (0.87)z 0 (0)
3þ 74 (11) 7 (7)
4þ 611 (88) 93 (93)
LV mass index (g/m2) 641 130  32 94 140  110 >.9
LA diameter (cm) 600 4.6  0.76 87 4.6  0.67 .5
LV end-diastolic volume (mL) 644 150  45 95 160  44 .4
LV end-systolic volume (mL) 636 47  23 95 49  24 .4
LV mass (g) 641 260  72 94 280  220 .7
LV ejection fraction (%) 681 58  6.3 100 58  7.0 .3
RVSP (mm Hg) 397 36  8.4 61 36  8.6 .9
Pulmonary regurgitation grade 692 100 .4
0 679 (98) 100 (100)
1þ 10 (1.4) 0 (0)
2þ 3 (0.43) 0 (0)
Data presented as mean standard deviation or n (%). BUN, Blood urea nitrogen; LA, left atrial; LV, left ventricular;NYHA, NewYork Heart Association; RVSP, right ventricular
systolic pressure. *Patients with data available. yLVOT. zFive patients with LVOT and 1 with long-standing atrial fibrillation, failed medical therapy, and progressive left-sided
heart failure.
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TABLE E4. Patient characteristics for tricuspid regurgitation grade 1þgroup
Variable
Patients not included Patients included
P valuePatients (n)* Value Patients (n)* Value
Demographics
Age (y) 545 56  12 100 57  12 .9
Women 545 189 (35) 100 37 (37) .7
Body surface area (m2) 545 2.0  0.24 100 2.0  0.25 .2
Cardiac morbidity
NYHA functional class 545 100 .2
I 199 (37) 28 (28)
II 277 (51) 63 (63)
III 63 (12) 8 (8)
IV 6 (1.1) 1 (1)
Noncardiac comorbidity
Cholesterol (mg/dL) 495 190  39 87 200  43 .2
Bilirubin (mg/dL) 526 0.75  0.47 97 0.74  0.39 >.9
BUN (mg/dL) 537 18  5.4 100 18  5.3 .4
Creatinine (mg/dL) 536 0.95  0.21 99 0.96  0.23 .8
Hematocrit (%) 533 41  4.3 99 41  5.4 .8
Echocardiography
Mitral regurgitation grade 545 100 .1
1þ 1 (0.18)y 0 (0)
2þ 0 (0) 1 (1)z
3þ 54 (9.9) 8 (8)
4þ 490 (90) 91 (91)
LV mass index (g/m2) 496 130  33 95 130  30 .2
LA diameter (cm) 469 4.8  0.82 92 4.7  0.81 .5
LV end-diastolic volume (mL) 499 150  49 97 150  46 .8
LV end-systolic volume (mL) 498 49  28 97 50  26 .4
LV mass (g) 496 260  78 95 250  73 .5
LV ejection fraction (%) 541 58  6.5 99 59  7.8 .07
RVSP (mm Hg) 430 40  10 86 42  12 .3
Pulmonary regurgitation grade 544 100 .6
0 147 (27) 24 (24)
1þ 395 (73) 75 (75)
2þ 2 (0.37) 1 (1.0)
Data presented as mean standard deviation or n (%). BUN, Blood urea nitrogen; LA, left atrial; LV, left ventricular; NYHA, New York Heart Association; RVSP, right ventricular
systolic pressure. *Patients with data available. yLVOT obstruction. zLong-standing atrial fibrillation, failed medical therapy.
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TABLE E5. Patient characteristics for tricuspid regurgitation grade 2þgroup
Variable
Patients not included Patients included
P valuePatients (n)* Value Patients (n)* Value
Demographics
Age (y) 203 64  12 100 65  12 .4
Women 203 93 (46) 100 34 (34) .05
Body surface area (m2) 203 1.9  0.25 100 2.0  0.23 .08
Cardiac morbidity
NYHA functional class 203 100 .4
I 55 (27) 36 (36)
II 115 (57) 52 (52)
III 28 (14) 11 (11)
IV 5 (2.5) 1 (1)
Noncardiac comorbidity
Cholesterol (mg/dL) 171 190  34 92 190  29 .3
Bilirubin (mg/dL) 193 0.85  0.6 99 0.8  0.41 .9
BUN (mg/dL) 201 19  6.0 100 19  6.0 >.9
Creatinine (mg/dL) 201 0.95  0.23 99 1.0  0.24 .1
Hematocrit (%) 200 40  4.4 99 41  4.0 .6
Echocardiography
Mitral regurgitation grade 203 100 .05
3þ 22 (11) 4 (4.0)
4þ 181 (89) 96 (96)
LV mass index (g/m2) 184 130  34 95 140  36 .5
LA diameter (cm) 167 4.9  0.86 93 5.0  0.85 .4
LV end-diastolic volume (mL) 184 150  46 95 150  45 .6
LV end-systolic volume (mL) 182 44  24 95 46  20 .3
LV mass (g) 184 250  73 95 270  80 .3
LV ejection fraction (%) 200 58  6.4 100 58  5.7 .9
RVSP (mm Hg) 176 48  15 95 50  13 .07
Pulmonary regurgitation grade 203 100 .4
0 21 (10) 7 (7)
1þ 21 (10) 7 (7)
2þ 161 (79) 86 (86)
Data presented as mean standard deviation or n (%). BUN, Blood urea nitrogen; LA, left atrial; LV, left ventricular;NYHA, NewYork Heart Association; RVSP, right ventricular
systolic pressure. *Patients with data available.
TABLE E6. Distribution of echocardiograms over time according to
tricuspid regurgitation grade
Follow-up
TR grade
0 1þ 2þ 3þ/4þ
Postoperative (predischarge) 97 (154) 100 (178) 100 (206) 93 (180)
1 mo 20 (42) 25 (54) 29 (81) 26 (55)
1 y 11 (17) 22 (137) 24 (62) 19 (36)
3 y 4 (5) 10 (12) 17 (32) 8 (12)
Data presented as number of patients, with number of echocardiograms in parenthe-
ses. TR, Tricuspid regurgitation.
TABLE E7. Postoperative (predischarge) tricuspid regurgitation
grades stratified by tricuspid valve procedure in patients with 0, 1þ,
2þ, and 3þ/4þpreoperative TR grade
Preoperative TR grade
Postoperative (predischarge) TR grade
0
(n ¼ 96)
1
(n ¼ 88)
2
(n ¼ 93)
3þ/4þ
(n ¼ 85)
0
Without TV surgery 19 (20) 8 (9.1) 2 (2.2) 0 (0)
With TV surgery — — 0 (0) 7 (13)
1þ
Without TV surgery 72 (75) 67 (76) 65 (72) 13 (45)
With TV surgery — — 1 (33) 44 (79)
2þ
Without TV surgery 4 (4.2) 11 (13) 18 (20) 12 (41)
With TV surgery — — 2 (67) 5 (8.9)
3þ/4þ
Without TV surgery 1 (1.0) 2 (2.3) 5 (5.6) 4 (14)
With TV surgery — — 0 (0) 0 (0)
Data presented as n (%). TR, Tricuspid regurgitation; TV, tricuspid valve.
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TABLE E8. Patient characteristics in tricuspid regurgitation grade 3þ/4þgroup stratified by use of tricuspid valve procedure
Variable
No TV procedure TV procedure
P valuePatients (n) Value Patients (n) Value
Atrial fibrillation/flutter 29 8 (28) 64 28 (44) .1
Heart failure 29 8 (28) 64 33 (52) .03
Hypertension 29 11 (38) 64 38 (59) .06
Resting heart rate (bpm) 29 75  13 64 82  19 .06
Resting CVP (mm Hg) 29 11  4.4 64 13  5.0 .01
LA diameter (cm) 26 4.7  0.81 58 5.2  0.96 .04
LV ejection fraction (%) 29 59  5.2 64 55  8.9 .06
RVSP (mm Hg) 29 47  22 64 49  22 .7
TV tethering distance (cm) 28 0.61  0.21 63 0.76  0.33 .06
TV tethering area (cm2) 28 0.53  0.26 63 0.83  0.63 .02
TAPSE (cm) 29 1.1  0.22 64 1.1  0.26 .8
MPI 29 0.85  0.29 64 0.81  0.27 .4
Cholesterol (mg/dL) 26 180  34 59 170  36 .1
BUN (mg/dL) 29 18  4.8 64 23  9.8 .03
Data presented as mean standard deviation or n (%). BUN, Blood urea nitrogen;CVP, central venous pressure; LA, left atrial; LV, left ventricular;MPI, myocardial performance
index; RVSP, right ventricular systolic pressure; TAPSE, tricuspid annular plane systolic excursion; TV, tricuspid valve.
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